Your shopping cart is currently empty

LipopeptideCPK4 TFA is a cholesterol-modified peptide K4 [(KIAALKE)3]. Upon binding with liposomes, LipopeptideCPK4 TFA can form a coiled-coil structure. It can facilitate the fusion of liposomes with live cell membranes and efficiently deliver various compounds to the cytoplasm, including fluorescent dyes Propidium Iodide (PI) and TO-PRO-3 iodide, as well as Doxorubicin (DOX). LipopeptideCPK4 TFA is applicable in drug delivery research.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | LipopeptideCPK4 TFA is a cholesterol-modified peptide K4 [(KIAALKE)3]. Upon binding with liposomes, LipopeptideCPK4 TFA can form a coiled-coil structure. It can facilitate the fusion of liposomes with live cell membranes and efficiently deliver various compounds to the cytoplasm, including fluorescent dyes Propidium Iodide (PI) and TO-PRO-3 iodide, as well as Doxorubicin (DOX). LipopeptideCPK4 TFA is applicable in drug delivery research. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.